Global Fluorescent in-situ Hybridization Fish Probe Market Overview
As per MRFR analysis, the Fluorescent in-situ Hybridization Fish Probe Market Size was estimated at 4.37 (USD Billion) in 2022.
The Fluorescent in-situ Hybridization Fish Probe Market is expected to grow from 4.46 (USD Billion) in 2023 to 5.4 (USD Billion) by 2032. The Fluorescent in-situ Hybridization Fish Probe Market CAGR (growth rate) is expected to be around 2.14% during the forecast period (2024 - 2032).
Key Fluorescent in-situ Hybridization Fish Probe Market Trends Highlighted
Fluorescent in-situ Hybridization (FISH) probes are widely used in cytogenetics and molecular diagnostics for detecting chromosomal abnormalities and genetic variations.
The FISH probe market is driven by the increasing prevalence of genetic disorders, advancements in cytogenetic techniques, and growing awareness of personalized medicine.
Other key drivers include the rise in cancer diagnostics, genomic research, and the development of multiplex FISH probes capable of detecting multiple targets simultaneously.
Recent trends in the FISH probe market include the emergence of automation and artificial intelligence (AI) in FISH analysis, which streamline and improve the accuracy of FISH testing.
Additionally, the development of probes with improved specificity and sensitivity enhances the detection of genetic abnormalities. Opportunities for the FISH probe market lie in the expansion of molecular diagnostics in emerging markets and the development of FISH probes for rare genetic disorders.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Fluorescent in-situ Hybridization Fish Probe Market Drivers
Increasing Demand for FISH-based Cancer Diagnostics
Fluorescent in-situ Hybridization (FISH) is an efficient cytogenetic technique implemented for detecting and characterizing chromosomal abnormalities.
The procedure requires the use of fluorescently labeled DNA probes capable of binding to the specific DNA sequences on the chromosomes; thus, providing the possibility to visualize and analyze the genetic alterations. FISH is known to be an efficient tool that can be deployed in cancer diagnostics in particular.
It is considered to be useful since it supports the identification of several types of genetic aberrations, which are likely to cause the development of cancer of different origins.
Nowadays, the increased prevalence of cancer and the raised need for on-time and accurate diagnostics are the factors that affect the growth of the Fluorescent in-situ Hybridization Fish Probe Market. Overall, FISH contributes to precise and sensitive diagnostics, allows for detecting numerical and structural abnormalities as well as the specific chromosome fusions, deletions, amplifications etc.
Moreover, the probes designed to bind to the specific locations on the chromosomes are known to support the identification of specific genetic aberrations; the latter can be associated with specific cancer types.
Thus, FISH contributes to the increased precision of the diagnostics and allows for making better decisions regarding patient management, treatment selection, and prognosis.
In the future, the use of FISH in cancer diagnostics will only grow due to the increased need for the development of personalized and targeted anticancer therapy.
Technological Advancements and Innovation
The Fluorescent in-situ Hybridization Fish Probe Market is constantly evolving, driven by technological advancements and innovation. Research and development efforts are focused on improving the sensitivity, specificity, and multiplexing capabilities of FISH probes.
The development of new fluorescent dyes and labeling techniques has enhanced the brightness and photostability of FISH signals, allowing for better visualization and analysis.
Additionally, advances in automation and image analysis software have streamlined the FISH workflow, making it more efficient and accessible.
The integration of FISH with other techniques, such as next-generation sequencing (NGS), is also gaining traction, providing a comprehensive approach to genetic analysis.
These technological advancements and innovations are expected to further expand the applications of FISH in both research and clinical settings.
Growing Adoption in Research and Academia
Fluorescence in situ hybridization is effectively utilized in research and academia to identify the genetic causes of diseases, determine the expression of genes and identify the nature of chromosomal rearrangements.
Since FISH has high specificity and sensitivity, it is the best technology to apply to investigate complex genetic manners in model organisms and human samples.
Development of FISH has contributed to deep understanding of various genetically based diseases including cancer and developmental and infectious diseases.
With the need for a profound understanding of human health and diseases, FISH is expected to continue gaining acceptance.
Fluorescent in-situ Hybridization Fish Probe Market Segment Insights
Fluorescent in-situ Hybridization Fish Probe Medical Application Insights
The biggest sub-segment within the Medical Application segment, Cancer Diagnostics accounts for more than 60% of the market.
The rise of cancer diagnostics is driven by the growing incidence of various types of cancer, with breast and lung cancer being the most common types among women and men, respectively. FISH probes are used to detect chromosomal abnormalities, gene amplifications, and deletions characteristic of different types of cancer, such as breast, lung, and hematologic malignancies.
Moreover, the rising use of personalized medicine and targeted therapies is driving the demand for FISH-based cancer diagnostics.
One of the sub-segments which will see modest growth in the following years, Prenatal Diagnostics serve the purpose of identifying genetic abnormalities in fetuses that might indicate the presence of such health conditions as Down syndrome, trisomy 18, and trisomy 13.
An increased availability of non-invasive prenatal testing mechanics has led to the solid growth of the sub-segment. Finally, Genetic Testing is the rapidly growing sub-segment which is led by the advances in the use of cancer diagnostics applications.
FISH probes are used to detect genetic mutations and variations indicative of the presence of such disorders as cystic fibrosis, sickle cell anemia, and muscular dystrophy.
Furthermore, the rise of personalized medicine and gene therapies will further drive the growth of the sub-segment in the years to come.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Fluorescent in-situ Hybridization Fish Probe Type Insights
On the basis of probe type, the Fluorescent in-situ Hybridization Fish Probe Market has been divided into DNA probes, RNA probes, and Multiplex probes. DNA probes are generally used as FISH probes and account for more than 60% of the market share in 2023.
This is because DNA probes have high specificity and sensitivity; they can detect normal as well as aberrant chromosomal abnormalities.
They are used to identify structural and numerical chromosome abnormalities which are associated with various types of cancer. RNA probes are also known as second generations since RNA is synthesized from genes.
RNA probes detect genes which are expressed and becoming more popular in the field of molecular diagnostics. Multiplex probes are used for the simultaneous detection of multiple targets which provides a comprehensive view of the genetic profile of the cell.
The growth of the market is primarily driven by the increasing adoption of the FISH technology for clinical diagnostics and research applications.
Fluorescent in-situ Hybridization Fish Probe Target Insights
The Fluorescent in-situ Hybridization Fish Probe Market is segmented into various targets, including Genes, Chromosomes, and Other genomic regions. The Genes segment held the largest market share in 2023 and is expected to continue its dominance over the forecast period.
The growth of this segment can be attributed to the increasing use of FISH probes in genetic testing and research.
The Chromosomes segment is expected to witness significant growth during the forecast period. This growth can be attributed to the rising demand for FISH probes in cancer diagnostics and prognostics.
The Other genomic regions segment is expected to register a steady growth rate during the forecast period. This growth can be attributed to the increasing demand for FISH probes in various applications, such as genetic testing, cancer diagnostics, and prognostics.
Fluorescent in-situ Hybridization Fish Probe Chemistry Insights
The Probe Chemistry segment is a crucial component of the Fluorescent in-situ Hybridization Fish Probe Market, influencing market growth and segmentation. Nick translation, random priming, and PCR amplification are key techniques used in probe chemistry.
Nick translation, a commonly used method, involves enzymatic nicking of DNA and subsequent incorporation of labeled nucleotides. Random priming utilizes random hexamers to prime DNA synthesis, while PCR amplification employs polymerase chain reaction to generate multiple copies of the target DNA.
In 2024, the Fluorescent in-situ Hybridization Fish Probe Market is expected to reach a valuation of $4.56 billion, with Probe Chemistry contributing significantly to this growth. Market data indicates that Nick translation holds a substantial market share due to its versatility and cost-effectiveness.
Random priming, known for its simplicity and speed, is projected to maintain a steady market presence. PCR amplification, with its high specificity and sensitivity, is gaining traction in specialized applications, particularly in research and diagnostic settings.
The ongoing advancements in probe chemistry, including the development of novel labeling techniques and improved probe designs, are expected to drive further market expansion in the coming years.
Fluorescent in-situ Hybridization Fish Probe End User Insights
The Fluorescent in-situ Hybridization Fish Probe Market is segmented into various end users, including hospitals and clinics, research laboratories, and forensic laboratories. Among these segments, hospitals and clinics held the largest market share in 2023, accounting for over 50% of the market revenue.
This dominance is attributed to the increasing prevalence of cancer and other genetic disorders, which require accurate and reliable diagnostic methods. Research laboratories are also significant end users, utilizing FISH probes for basic and translational research, contributing to the growth of the market.
Forensic laboratories use FISH probes for human identification and paternity testing, driving demand in this segment.
The increasing adoption of FISH probes in these end-user segments is fueling the overall growth of the Fluorescent in-situ Hybridization Fish Probe Market, which is anticipated to reach a market valuation of USD 4.46 billion in 2023 and is projected to grow at a CAGR of 2.14% to reach a valuation of USD 5.4 billion by 2032.
Fluorescent in-situ Hybridization Fish Probe Regional Insights
The Fluorescent in-situ Hybridization Fish Probe Market is segmented into North America, Europe, APAC, South America, and MEA. North America was the largest market for FISH probes, accounting for over 40% of the revenue in 2023.
The region is home to a large number of leading life sciences companies and research institutions, which drives the demand for FISH probes.
Europe is the second largest market, followed by APAC. The APAC region is expected to grow rapidly in the coming years due to the increasing adoption of FISH probes in emerging economies such as China and India.
South America and MEA are smaller markets, but they are expected to grow steadily in the coming years.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Fluorescent in-situ Hybridization Fish Probe Market Key Players and Competitive Insights
Major players in the Fluorescent in-situ Hybridization Fish Probe Market are constantly striving to gain a competitive edge by introducing innovative products and technologies.
Leading Fluorescent in-situ Hybridization Fish Probe Market players are focusing on expanding their presence and forming strategic partnerships to strengthen their market position. The Fluorescent in-situ Hybridization Fish Probe Market is characterized by intense competition among key players, with each company vying for a larger market share.
To stay ahead in the competitive landscape, companies are investing heavily in research and development to bring cutting-edge products to the market.
The Fluorescent in-situ Hybridization Fish Probe Market is witnessing the emergence of new players, which is further intensifying the competitive dynamics. These new entrants are bringing innovative ideas and technologies to the market, challenging the established players.
Roche, a leading player in the Fluorescent in-situ Hybridization Fish Probe Market, has established a strong market position through its commitment to innovation and customer satisfaction.
The company offers a comprehensive portfolio of FISH probes for various applications, including cancer diagnostics, genetic testing, and research.
Roche's FISH probes are known for their high sensitivity, specificity, and accuracy, making them a preferred choice among healthcare professionals. The company's presence and extensive distribution network enable it to cater to a wide range of customers worldwide.
Additionally, Roche's strong financial performance and investment in research and development further solidify its position as a leader in the Fluorescent in-situ Hybridization Fish Probe Market.
Agilent Technologies, a formidable competitor in the Fluorescent in-situ Hybridization Fish Probe Market, has gained a significant market share through its advanced technologies and strategic partnerships.
The company's FISH probes are designed to provide accurate and reliable results in cytogenetic and molecular diagnostic applications. Agilent's commitment to quality and innovation has earned it a reputation for excellence among customers.
The company's reach and distribution network allows it to cater to a diverse customer base across various regions. Agilent's focus on expanding its product portfolio and forming strategic alliances with key players in the healthcare industry positions it as a strong competitor in the Fluorescent in-situ Hybridization Fish Probe Market
Key Companies in the Fluorescent in-situ Hybridization Fish Probe Market Include
- Qiagen
- PathVysion
- Becton Dickinson and Company
- Leica Biosystems
- Biocept
- Agilent Technologies
- BioRad Laboratories
- Cytocell
- Myriad Genetics
- Thermo Fisher Scientific
- MetaSystems
- Enzo Biochem
- Roche Holding AG
- Dako Denmark A/S
- Abbott Molecular
Fluorescent in-situ Hybridization Fish Probe Market Developments
The market growth is attributed to the increasing prevalence of cancer, technological advancements in FISH techniques, and rising demand for personalized medicine.
Key market players include Abbott, Agilent Technologies, Bio-Rad Laboratories, and Danaher Corporation. Recent developments include the launch of new FISH probes for various cancer types and the development of automated FISH systems to streamline the workflow.
The market is expected to witness significant growth in emerging economies, driven by increasing healthcare expenditure and rising awareness about genetic testing.
Fluorescent in-situ Hybridization Fish Probe Market Segmentation
Fluorescent in-situ Hybridization Fish Probe Medical Application Outlook
- Cancer diagnostics
- Prenatal diagnostics
- Genetic testing
Fluorescent in-situ Hybridization Fish Probe Type Outlook
- DNA probes
- RNA probes
- Multiplex probes
Fluorescent in-situ Hybridization Fish Probe Target Outlook
- Genes
- Chromosomes
- Other genomic regions
Fluorescent in-situ Hybridization Fish Probe Chemistry Outlook
- Nick translation
- Random priming
- PCR amplification
Fluorescent in-situ Hybridization Fish Probe End User Outlook
- Hospitals and clinics
- Research laboratories
- Forensic laboratories
Fluorescent in-situ Hybridization Fish Probe Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
|
Report Attribute/Metric
|
Details
|
|
Market Size 2022
|
4.37 (USD Billion)
|
|
Market Size 2023
|
4.46 (USD Billion)
|
|
Market Size 2032
|
5.4 (USD Billion)
|
|
Compound Annual Growth Rate (CAGR)
|
2.14% (2024 - 2032)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Base Year
|
2023
|
|
Market Forecast Period
|
2024 - 2032
|
|
Historical Data
|
2019 - 2023
|
|
Market Forecast Units
|
USD Billion
|
|
Key Companies Profiled
|
Qiagen, PathVysion, Becton Dickinson and Company, Leica Biosystems, Biocept, Agilent Technologies, BioRad Laboratories, Cytocell, Myriad Genetics, Thermo Fisher Scientific, MetaSystems, Enzo Biochem, Roche Holding AG, Dako Denmark A/S, Abbott Molecular
|
|
Segments Covered
|
Medical Application, Probe Type, Target, Probe Chemistry, End User, Regional
|
|
Key Market Opportunities
|
Increasing demand for FISH probe-based molecular diagnostics
Growing adoption of personalized medicine
Advancements in FISH probe technology
Rising prevalence of cancer and genetic diseases
Technological innovations in FISH probe development
|
|
Key Market Dynamics
|
Increasing cancer prevalence
Technological advancements
Expanding applications in genetic testing
Rising demand for personalized medicine
Growing adoption in research and diagnostics
|
|
Countries Covered
|
North America, Europe, APAC, South America, MEA
|
Frequently Asked Questions (FAQ) :
The Fluorescent in-situ Hybridization Fish Probe Market size was around USD 4.46 billion in 2023.
The Fluorescent in-situ Hybridization Fish Probe Market is projected to grow at a CAGR of 2.14% from 2024 to 2032.
North America dominated the Fluorescent in-situ Hybridization Fish Probe Market in 2023.
The oncology segment held the largest share of the Fluorescent in-situ Hybridization Fish Probe Market in 2023.
Key competitors in the Fluorescent in-situ Hybridization Fish Probe Market include Abbott, Agilent Technologies, Bio-Rad Laboratories, Danaher, and F. Hoffmann-La Roche
Major factors driving the growth of the Fluorescent in-situ Hybridization Fish Probe Market include the rising incidence of cancer, increasing demand for personalized medicine, and technological advancements.
Key challenges faced by the Fluorescent in-situ Hybridization Fish Probe Market include the high cost of FISH probes, lack of skilled professionals, and stringent regulatory requirements.
Key opportunities for the Fluorescent in-situ Hybridization Fish Probe Market include the growing adoption of FISH in developing countries, increasing awareness about FISH, and the development of new FISH probes.
The Fluorescent in-situ Hybridization Fish Probe Market is expected to reach around USD 5.4 billion by 2032
The Asia Pacific region is expected to witness the fastest growth in the Fluorescent in-situ Hybridization Fish Probe Market from 2024 to 2032
